Efficacy of Rechallenge With Sunitinib in Metastatic Pancreatic Neuroendocrine Tumor Previously Failed to Sunitinib
Clinical trial NCT02713763 · COMPLETED
Trial details
- NCT number
- NCT02713763
- Sponsor
- Grupo Espanol de Tumores Neuroendocrinos
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-14
- Primary completion
- 2019-10-23
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.